论文部分内容阅读
目的观察10-18周产妇应用米非司酮配伍米索前列醇终止妊娠的临床效果。方法取2015年4月-2016年4月自愿到我院行终止妊娠的120例孕妇为研究对象,按终止妊娠方法不同分为米非司酮配伍米索前列醇引产的观察组与行羊膜腔穿刺注射利凡诺引产的对照组,将两组流产效果与不良反应发生情况作以比较。结果观察组完全流产率为71.7%明显高于对照组45.0%(P<0.05)。结论对于妊娠10-18周且有流产需求的孕妇而言建议采用米非司酮配伍米索前列醇进行引产。
Objective To observe the clinical effect of maternal mifepristone and misoprostol in 10-18 weeks maternal termination of pregnancy. Methods From April 2015 to April 2016, 120 pregnant women who voluntarily came to our hospital for termination of pregnancy were enrolled. According to the method of terminating pregnancy, the observation group divided into mifepristone and misoprostol induced labor and the amniotic cavity Puncture and injection of rivano induced labor control group, the two groups abortion effect and adverse reactions for comparison. Results The abortion rate in observation group was 71.7%, which was significantly higher than that in control group (45.0%, P <0.05). Conclusion For pregnant women 10-18 weeks of gestation and abortion requirements, it is recommended to use mifepristone with misoprostol for induction of labor.